Skip to main content

28 October 2025

Last updated: Monday 27 October 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Noxxon Pharma develops mirror-image oligonucleotides

Thursday 4 March 2010

Interviewee/Contributor

Sven Klussmann

Organisation

Noxxon Pharma AG

Organisations

NDA Group
Complement Therapeutics Ltd
Terumo Blood and Cell Technologies
Silence Therapeutics Plc
Cellzome
Novo Nordisk Foundation
Cell Therapy Catapult Ltd
London Stock Exchange
Immatics Biotechnologies GmbH
International Society Cell and Gene Therapy

Interviewees and Contributers

Antonella Folgori
Shiva Memari
Philip Vanek
Thomas Lönngren
Jónas Einarsson
Øystein Rekdal
Riccardo Panella
Rudy Dekeyser
Nicholas Adams
Douglas Melton

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Siegfried Holding nominates new chairman

Saturday 25 October 2025

Epitopea makes four appointments to SAB

Saturday 25 October 2025

Exciting Instruments appoints chairman

Saturday 25 October 2025

Zealand Pharma appoints communications VP

Saturday 25 October 2025

Immunotherapy expert joins Pathios Therapeutics board

Saturday 25 October 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form